Cyril Daveu
Sanofi (France)(FR)Sanofi (Germany)(DE)
Publications by Year
Research Areas
Computational Drug Discovery Methods, Receptor Mechanisms and Signaling, Synthesis and Biological Evaluation, Analytical Chemistry and Chromatography, Chemical Synthesis and Analysis
Most-Cited Works
- → Oxidation and Nitration of Catecholamines by Nitrogen Oxides Derived from Nitric Oxide(1997)99 cited
- → Reversion of cardiac dysfunction by a novel orally available calcium/calmodulin-dependent protein kinase II inhibitor, RA306, in a genetic model of dilated cardiomyopathy(2019)54 cited
- → Precise Engineering of Multifunctional PEGylated Polyester Nanoparticles for Cancer Cell Targeting and Imaging(2014)53 cited
- → Definition of a Pharmacophore for Partial Agonists of Serotonin 5-HT3 Receptors(1999)35 cited
- → Molecular Design Based on 3D-Pharmacophore. Application to 5-HT Subtypes Receptors(2002)20 cited
- → Novel antagonists of serotonin-4 receptors: Synthesis and biological evaluation of pyrrolothienopyrazines(2008)17 cited
- → Association of Two 3D QSAR Analyses. Application to the Study of Partial Agonist Serotonin-3 Ligands(2001)15 cited
- → SAR340835, a Novel Selective Na+/Ca2+ Exchanger Inhibitor, Improves Cardiac Function and Restores Sympathovagal Balance in Heart Failure(2021)14 cited
- → First tricyclic oximino derivatives as 5-HT3 ligands(2001)13 cited
- → Molecular Design Based on 3D-Pharmacophore. Application to 5-HT4 Receptor(2002)12 cited